Acetylglucosamine Market: Global Industry Analysis and Forecast (2023-2029) Trends, Statistics, Dynamics, Segmentation by Form, Source, Application, and Region

The Global Acetylglucosamine Market size was valued at $478.36 Million in 2022 and the total Acetylglucosamine Market revenue is expected to grow at a CAGR of 7.4% from 2023 to 2029, reaching nearly $788.48 Million Acetylglucosamine(NAG) is an amino-monosaccharide that occurs naturally and serves as the primary monomeric component of the homogeneous polysaccharide chitin. Chitin, one of the most prevalent polymers in nature, and its monomer NAG are present in the shells of crustaceans, the exoskeletons of insects, and the cell walls of fungi. The heterogeneous polysaccharide hyaluronic acid (HA), which is made up of repeated D-glucuronic acid and NAG residues, contains NAG in humans. In the dermal layer of the skin, where it gives structure, controls neighbouring cells, and maintains optimal water content, HA, a key component of connective tissue, is widely distributed. This promotes skin moisture and suppleness. One of the most essential bioactive supplements for intestinal health is N-Acetyl Glucosamine, which "repairs" the gut lining after years of stress, antibiotics, and spicy, acidic food. NAG repairs the intestinal lining and promotes the growth of beneficial bacteria, which is vital for colon health. Recent investigations have indicated modest efficacy when used as a therapy for autoimmune diseases. N-acetylglucosamine (NAG) has made a name for itself as a valuable component of drugs, nutraceuticals, and cosmetics. However, NAG was already a crucial component of many creatures, including shellfish, fungi, and even humans, long before it was investigated for its medicinal and beauty effects. Additionally, glucosamine has been shown to have antioxidant activity and to be helpful in experimental arthritis in animals. N-acetyl glucosamine is used to treat osteoarthritis and inflammatory bowel diseases (IBD), such as Crohn's and ulcerative colitis. According to one cell-based study. NAG is more effective at producing hyaluronic acid, making it possibly healthier for the skin, joints, and other elastic tissues, A neck and decolletage lotion containing N-acetylglucosamine (NAG) regenerated the skin and eliminated age spots in 42 older women. Women who used the cream saw a noticeable improvement in their skin tone. increases the skin's synthesis of hyaluronic acid and repairs the sun's damage. These aspects are anticipated to boost acetylglucosamine market growth during the forecast period.

Acetylglucosamine Market Scope and Research Methodology:

The acetylglucosamine market report provides a wide-ranging analysis of the global market in the food and beverages industry. It covers various aspects such as form, source, application, and region. It also gives knowledge about the growth drivers, upcoming challenges, trends, and opportunities. The research methodology involves analyzing product-type literature, industry releases, annual reports, and other relevant documents of key industry participants. The report highlights the product’s competitive position and focuses on technological advancements to establish dominance in the global acetylglucosamine market. Key players are also strengthening their market positions by implementing market strategies such as product launches, R&D development, joint venture, and mergers & acquisitions. Overall, the report aims to offer valuable insights and an in-depth analysis of the acetylglucosamine market to assist investors in making decisions and understanding market dynamics related to the food industry.Acetylglucosamine MarketTo know about the Research Methodology :- Request Free Sample Report

Acetylglucosamine Market Dynamics:

An Increase in Prevalence of Various Diseases is Driving the Acetylglucosamine Market Growth One of the main factors driving the growth of the acetylglucosamine market is the rising prevalence of chronic diseases such as diabetes, cancer, and obesity as a result of poor nutrition, a hectic lifestyle, and high demand for dietary fibres in functional food and beverage items. Another important driver projected to promote the growth of the worldwide acetylglucosamine market throughout the forecast period is the increasing use of acetylglucosamine in the pharmaceutical industry to treat various cardiovascular diseases, diabetes, and blood pressure. Acetyl glucosamine-containing nutritional supplements enhance joint health by giving the body the nutrients it needs for general wellness. In dietary supplements, acetylglucosamine also functions as a substitute for sugar, which is anticipated to boost the acetylglucosamine market. According to the World Health Organisation (WHO), obesity and overweight are key risk factors for developing chronic diseases or cardiovascular diseases, which account for the majority of fatalities worldwide which leads to the growth of the global acetylglucosamine market in the forecast period. High Cost of Acetylglucosamine Restrain the Growth of the Global Acetylglucosamine Market The high cost of acetylglucosamine, as well as the availability of various substitutes such as omega three fatty acids, collagens, and fish oils, are important factors restricting the growth of the acetylglucosamine market. Side effects such as stomach discomfort, constipation, diarrhoea, and headaches are also limiting the market for acetylglucosamine. Many joints and health supplements are more expensive, making it difficult for every patient to buy them. Several private hospitals and clinics demand exorbitant fees for these supplements, and many patients opt to avoid taking them, limiting the acetylglucosamine market growth. Rising Ratio of Diseases and Growing the Number of Manufacturers across the World to Foster the Growth of the Acetylglucosamine Market The geriatric population is more prone to bone fractures and injuries. Rheumatoid arthritis is one of the most common autoimmune diseases afflicting people globally. In response to the increased number of people suffering from osteoporosis and rheumatoid arthritis, manufacturers are now creating collagen-based candies, supplements, and drinks. These products are beneficial when used orally. According to WHO statistics, in 2021 around 14 million people have rheumatoid arthritis globally which is anticipated to boost the acetylglucosamine market trend in the upcoming years. N-acetylglucosamine has been shown to diminish face hyperpigmentation by reducing melanin formation, while acetylglucosamine has been shown to protect skin cells from free radicals. As a result, manufacturers are seizing value-added opportunities in cosmetics and personal care goods. N-acetylglucosamine is being studied for its ability to brighten the skin's complexion and its anti-ageing qualities, acetylglucosamine which helps to relieve age spots caused by prolonged exposure to UV (ultraviolet) radiation. Companies in the acetylglucosamine industry are conducting more studies into the skin-brightening effects of N-acetylglucosamine, which is enhanced when combined with niacinamide in acetylglucosamine skincare products. These factors are estimated to grow the acetylglucosamine market share.

Acetylglucosamine Market Segment Analysis:

Based on forms, the market has been divided into powder and liquid. Among these, the liquid sub-segment is projected to generate the maximum revenue. Liquid sub-segment is the most common type of glucosamine forms is showed a faster absorption rate compared with solids acetylglucosamine, better intake route—especially for those who struggle to chew conventional solid dosage forms of acetylglucosamine—and greater dosing flexibility. In addition, the flavouring profile can be customised to the patient's tastes. This liquid form sub-segment is predicted to propel the acetylglucosamine market opportunity. Based on source, the market has been divided into crustaceans, fungi, arachnids, and others. Among these, the crustaceans sub-segment is projected to generate the maximum revenue. The crustaceans sub-segment witnessed the highest revenue in 2022. Crustacean shells are made up of protein and calcium carbonate, but primarily of chitin. Chitin is a long-chain, linear sugar-like polymer composed of acetylglucosamine, a glucose derivative. Monomeric acetylglucosamine units have the potential to be useful raw materials in the polymer sector. The shell of a crab is made up of 30-40% protein, 30-50% calcium carbonate and calcium phosphate, and 20-30% chitin. Chitin was extracted from shrimp shells by deproteinization, depigmentation, and demineralization. A Despite its accessible availability and massive annual output, chitin remains the most underutilised resource due to its intractable molecular structure. As a biomaterial with potential applications in a variety of disciplines, it is critical to study using the different procedures, the many end products that can be created from crustacean shell waste which is likely to drive the growth of the acetylglucosamine market demand during the forecast period. Based on application, the market has been divided into dietary supplements, pharmaceuticals, cosmetics & personal care, and others. Among these, the dietary supplements sub-segment is projected to generate the maximum revenue. The dietary supplements sub-segment of acetylglucosamine witnessed the highest market share including people adopting healthier lifestyles with the support of nutritional supplements as a result of increased health awareness and disposable income. Companies are focusing on the release of new dietary supplements to improve consumer well-being, prevent diseases, correct nutritional deficiencies, and capitalise on this trend. The product is primarily made from crustaceans such as prawns and crabs. However, increased allergy rates and the growing number of vegans, notably in the US, have prompted manufacturers to develop the product. The rising number of rheumatic patients, the rise of the desk-bound current workforce in both developed and developing countries, rising levels of obesity, rising use of dietary supplements, which in turn increases the use of glucosamine, the product's ability to help with joint pain relief, and growing investment in the development of novel vegan-friendly glucosamine supplements are the key drivers of this growth. A balanced diet is essential for good health, and many alternatives, as well as holistic therapists, offer food counselling. Many patients suffering from arthritis, including inflammatory and osteoarthritis that is to be beneficial due to dietary changes. Glucosamine is a supplement that is frequently used to treat and prevent joint problems such as osteoarthritis. It can be ingested or applied topically as a gel or balm. As a result of the global increase in desk occupations, diseases and joint problems are becoming increasingly widespread. This necessitates more manageable eating habits that can be incorporated into one's daily activities without disrupting one's way of life. Glucosamine is becoming a supplement that is helpful in a variety of illnesses.

Acetylglucosamine Market Regional Insights:

The North American region is predicted to hold the highest market share over the forecast period. The North American region is expected to be the dominant region in the acetylglucosamine market trend. Higher rates of obesity, the development of vegetarian-friendly glucosamine due to the prevalence of vegan diets, the rising need for nutritional supplements, which boosts the usage of glucosamine, and an increase in the number of arthritis patients are the main reasons for this dominance. Obesity rates in the US have more than doubled since 1960, with one-third of the population over the age of 18 obese. Even more worrying is the rise in the proportion of overweight females, which has risen from 6% to 19% in the last 25 years. Glucosamine supplementation has been demonstrated to help in weight loss while also enhancing joint function. The increasing food service industry is expected to propel the acetylglucosamine market demand in the forecast years.

Competitive Landscape

Key Players of the Acetylglucosamine market profiled in the report include Bio-gen Extracts Private Limited, AdvoCare, Amicogen, Inc., Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech Co., Ltd., Merck KGaA, Carl Roth, Yaizu Suisankagaku, Kaneka Corporation, Ethical Naturals Inc., NOW Foods, Beloor Bayir, Vitaco Health Limited, Pure Encapsulations, LLC, Kraeber & Co GmbH, Source Naturals, Inc., and NutriCology. Product launches, joint ventures, and mergers & acquisitions are common strategies followed by major market key players. For instance, in Dec 2021, in Germany, Merck, a major scientific and technology company, announced the formation of M Ventures, a strategic corporate project capital arm. M Ventures new €600 million investment is going to be spread out over the following five years. M Ventures is going to keep investing in visionary companies that discover new ways to treat the diseases, provide cutting-edge research and development tools to scientists, develop new technologies to improve the way information is accessed, stored, processed, and displayed, and provide innovative approaches for better sustainability in the science and technology ecosystem.

Acetylglucosamine Market Scope: Inquire before buying

Acetylglucosamine Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 478.36 Mn.
Forecast Period 2023 to 2029 CAGR: 4.5% Market Size in 2029: US $ 788.48 Mn.
Segments Covered: by Forms Powder Liquid
by Source Crustaceans Fungi Arachnids Others
by Applications Dietary Supplements Pharmaceuticals Cosmetics & Personal Care Others

Acetylglucosamine Market Regional Insights:

North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina, and the Rest of South America)

Acetylglucosamine Market Key Players:

1. Bio-gen Extracts Private Limited 2. AdvoCare 3. Amicogen, Inc. 4. Golden-Shell Pharmaceutical 5. Zhejiang Fengrun Biotech Co., Ltd. 6. Merck KGaA 7. Carl Roth 8. Yaizu Suisankagaku 9. Kaneka Corporation 10. Ethical Naturals Inc. 11. NOW Foods 12. Beloor Bayir 13. Vitaco Health Limited 14. Pure Encapsulations, LLC 15. Kraeber & Co GmbH 16. Source Naturals, Inc. 17. NutriCology

FAQs:

1. What are the growth drivers for the acetylglucosamine market? Ans. A Rise in obesity and arthritis diseases is expected to be the major driver for the acetylglucosamine market. 2. What is the major restraint for the acetylglucosamine market growth? Ans. The high cost of acetylglucosamine is expected to be the major restraining factor for the acetylglucosamine market growth. 3. Which region is expected to lead the global acetylglucosamine market during the forecast period? Ans. North America is expected to lead the global acetylglucosamine market during the forecast period. 4. What is the projected market size & growth rate of the acetylglucosamine market? Ans. The acetylglucosamine market size was valued at $478.36 Million in 2022 and the total acetylglucosamine market revenue is expected to grow at a CAGR of 7.4% from 2022 to 2029, reaching nearly $788.48 Million. 5. What segments are covered in the acetylglucosamine market report? Ans. The segments covered in the acetylglucosamine market report are forms, source, application, and region.
1. Acetylglucosamine Market: Research Methodology 2. Acetylglucosamine Market: Executive Summary 3. Acetylglucosamine Market: Competitive Landscape 3.1. MMR Competition Matrix 3.2. Competitive Landscape 3.3. Key Players Benchmarking 3.4. Market Structure 3.4.1. Market Leaders 3.4.2. Market Followers 3.4.3. Emerging Players 3.5. Consolidation of the Market 4. Acetylglucosamine Market: Dynamics 4.1. Market Trends by Region 4.1.1. North America 4.1.2. Europe 4.1.3. Asia Pacific 4.1.4. Middle East and Africa 4.1.5. South America 4.2. Market Drivers by Region 4.2.1. North America 4.2.2. Europe 4.2.3. Asia Pacific 4.2.4. Middle East and Africa 4.2.5. South America 4.3. Market Restraints 4.4. Market Opportunities 4.5. Market Challenges 4.6. PORTER’s Five Forces Analysis 4.7. PESTLE Analysis 4.8. Value Chain Analysis 4.9. Regulatory Landscape by Region 4.9.1. North America 4.9.2. Europe 4.9.3. Asia Pacific 4.9.4. Middle East and Africa 4.9.5. South America 5. Acetylglucosamine Market: Segmentation (by Value USD) 5.1. Acetylglucosamine Market, by Forms (2022-2029) 5.1.1. Powder 5.1.2. Liquid 5.2. Acetylglucosamine Market, by Source (2022-2029) 5.2.1. Crustaceans 5.2.2. Fungi 5.2.3. Arachnids 5.2.4. Others 5.3. Acetylglucosamine Market, by Application (2022-2029) 5.3.1. Dietary Supplements 5.3.2. Pharmaceuticals 5.3.3. Cosmetics & Personal Care 5.3.4. Others 5.4. Acetylglucosamine Market, by Region (2022-2029) 5.4.1. North America 5.4.2. Europe 5.4.3. Asia Pacific 5.4.4. Middle East and Africa 5.4.5. South America 6. North America Acetylglucosamine Market (by Value USD) 6.1. North America Acetylglucosamine Market, by Forms (2022-2029) 6.1.1. Powder 6.1.2. Liquid 6.2. North America Acetylglucosamine Market, by Source (2022-2029) 6.2.1. Crustaceans 6.2.2. Fungi 6.2.3. Arachnids 6.2.4. Others 6.3. North America Acetylglucosamine Market, by Application (2022-2029) 6.3.1. Dietary Supplements 6.3.2. Pharmaceuticals 6.3.3. Cosmetics & Personal Care 6.3.4. Others 6.4. North America Acetylglucosamine Market, by Country (2022-2029) 6.4.1. United States 6.4.2. Canada 6.4.3. Mexico 7. Europe Acetylglucosamine Market (by Value USD) 7.1. Europe Acetylglucosamine Market, by Forms (2022-2029) 7.2. Europe Acetylglucosamine Market, by Source (2022-2029) 7.3. Europe Acetylglucosamine Market, by Application (2022-2029) 7.4. Europe Acetylglucosamine Market, by Country (2022-2029) 7.4.1. UK 7.4.2. France 7.4.3. Germany 7.4.4. Italy 7.4.5. Spain 7.4.6. Sweden 7.4.7. Austria 7.4.8. Rest of Europe 8. Asia Pacific Acetylglucosamine Market (by Value USD) 8.1. Asia Pacific Acetylglucosamine Market, by Forms (2022-2029) 8.2. Asia Pacific Acetylglucosamine Market, by Source (2022-2029) 8.3. Asia Pacific Acetylglucosamine Market, by Application (2022-2029) 8.4. Asia Pacific Acetylglucosamine Market, by Country (2022-2029) 8.4.1. China 8.4.2. S Korea 8.4.3. Japan 8.4.4. India 8.4.5. Australia 8.4.6. Indonesia 8.4.7. Malaysia 8.4.8. Vietnam 8.4.9. Taiwan 8.4.10. Bangladesh 8.4.11. Pakistan 8.4.12. Rest of Asia Pacific 9. Middle East and Africa Acetylglucosamine Market (by Value USD) 9.1. Middle East and Africa Acetylglucosamine Market, by Forms (2022-2029) 9.2. Middle East and Africa Acetylglucosamine Market, by Source (2022-2029) 9.3. Middle East and Africa Acetylglucosamine Market, by Application (2022-2029) 9.4. Middle East and Africa Acetylglucosamine Market, by Country (2022-2029) 9.4.1. South Africa 9.4.2. GCC 9.4.3. Egypt 9.4.4. Nigeria 9.4.5. Rest of ME&A 10. South America Acetylglucosamine Market (by Value USD) 10.1. South America Acetylglucosamine Market, by Forms (2022-2029) 10.2. South America Acetylglucosamine Market, by Source (2022-2029) 10.3. South America Acetylglucosamine Market, by Application (2022-2029) 10.4. South America Acetylglucosamine Market, by Country (2022-2029) 10.4.1. Brazil 10.4.2. Argentina 10.4.3. Rest of South America 11. Company Profile: Key players 11.1. Bio-gen Extracts Private Limited 11.1.1. Company Overview 11.1.2. Financial Overview 11.1.3. Business Portfolio 11.1.4. SWOT Analysis 11.1.5. Business Strategy 11.1.6. Recent Developments 11.2. AdvoCare 11.3. Amicogen, Inc. 11.4. Golden-Shell Pharmaceutical 11.5. Zhejiang Fengrun Biotech Co., Ltd. 11.6. Merck KGaA 11.7. Carl Roth 11.8. Yaizu Suisankagaku 11.9. Kaneka Corporation 11.10. Ethical Naturals Inc. 11.11. NOW Foods 11.12. Beloor Bayir 11.13. Vitaco Health Limited 11.14. Pure Encapsulations, LLC 11.15. Kraeber & Co GmbH 11.16. Source Naturals, Inc. 11.17. NutriCology 12. Key Findings 13. Industry Recommendation
  • INQUIRE BEFORE BUYING